Mordor Intelligence released its 2018 list of the companies with the greatest influence on the molecular cytogenetics market.
According to the report, here are some of the top global players:
1. Agilent Technologies Inc.
Agilent is one of the major multinational players providing microarrays for comparative genomic hybridization, to be used by customers in cytogenetic laboratories. The company has a broad portfolio, offering immunohistochemistry, in-situ hybridization, and hematoxylin and eosin staining, which contribute largely to the molecular cytogenetics market. With a customer base of more than 11,000 across the world in its diagnostic and genomics business, a strong market share is expected over the forecast period.
Abbott is one of the major well-established companies producing diagnostics products and tests, which are manufactured, marketed, and sold across the world, including a broad line of products with applications in core laboratory systems, molecular diagnostics, point-of-care systems, and rapid diagnostics systems. The Molecular division of the company is actively involved in producing in-vitro diagnostic products and next-generation instrument systems for a range of genomic-based tests. Thus, a substantial growth in market share is expected for the company over the forecast period.
3. Bio-Rad Laboratories Inc.
Bio-Rad Laboratories has a stronghold in the life sciences industry and primarily focuses on proteomics, genomics, and biopharmaceutical production. The company has a vast range of reagents, apparatus, and laboratory instruments to provide its service for the range of customers. The company is expected to face stiff competition, in terms of meeting performance specifications and offering complete solutions, when compared to other multinational companies in the molecular cytogenetics market. The Life Sciences segment sales are booming, with nearly double-digit percentage growth each year. With that, over the forecast period, a consistent growth, facilitated by the strong global reach of the company, is expected during the forecast period.
4. Quest Diagnostics Incorporated
Quest is one of the leading companies in providing the diagnostic information services. The company has a large focus towards assessment of DNA profiling in a variety of cancer types and help advance precision medicine with genomic tumor sequencing. General Diagnostics has provided the company a strong cash flow and the company is now highly investing in advanced diagnostics and associated services for faster growth. The company is expected to grow through strategic partnerships with hospital chains, extended care services and acquisition in the Asia Pacific region over the forecast period.
Here are some of the other key players mentioned in the report:
Applied Spectral Imaging Inc.
F. Hoffmann-La Roche Ltd
Thermo Fisher Scientific
About Molecular Cytogenetics Market
The Mordor Intelligence report estimates that the global molecular cytogenetics market is to register a CAGR of about 10.5% over the forecast period of 2018-2023, with an upsurge in the demand for targeted therapy in cancer treatment, funding for research and clinical diagnostics, and growing prevalence of cancer and genetic disorders.
Mordor Intelligence is a market intelligence and advisory firm, operating in 14 industry segments, serving over 600 clients across the world.